Skip to main content
. 2024 Nov 11;30:209. doi: 10.1186/s10020-024-00934-4

Fig. 1.

Fig. 1

Clinicopathological characteristics of NSCLC patients and PDX tumor growth characteristics. A Clinicopathological characteristics of NSCLC patients. ADC, adenocarcinoma; SCC, squamous cell carcinoma; LCNEC, Large cell neuroendocrine carcinoma; LUL, left upper lobe; RLL, right lower lobe; RML, right middle lobe; LLL, left lower lobe; RUL, right upper lobe. B Kaplan–Meier curves for DFS and OS of NSCLC patients according to the engraftment status of their corresponding PDXs. Kaplan–Meier survival analysis and log-rank test were used to perform the survival analysis (No-PDX: n = 49; PDX: n = 13). C The scatter plot represents the time to reach 300 mm3 tumor volume in mice; each point represents the time taken for a tumor to reach 300mm3. D Growth curves of PDX engrafted tumors from 9 ADC patients. E Growth curves of PDX engrafted tumors from 4 SCC patients. F Growth curves of 3 PDX engrafted tumors from one LCNEC patient